CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Curocell Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Curocell Inc
11, Gukjegwahwa16-ro, Yuseong-gu
Phone: +82 428633698p:+82 428633698 DAEJEON, 34002  South Korea Ticker: 372320372320
Business Summary
Curocell Inc is a Korea-based company principally engaged in the manufacture, research and development (R&D) of drugs. The Company is also engaged in the development of novel chimeric antigen receptor (CAR)-T therapy technologies targeting novel cancer antigen, the development of CAR-T therapy technologies improving medicinal effect, the development of CAR-T therapy technologies improving existing side effects and the development of CAR-T therapy technologies automating quality analysis.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Co-Founder, Director Gun SooKim
Co-Founder Chan HyukKim
Co-Founder Hyun BoSim
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 102 (As of 12/31/2023)
Outstanding Shares: 14,090,125 (As of 4/24/2024)
Shareholders: 14,775
Stock Exchange: KDQ
Fax Number: +82 428633695


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024